The latest closing stock price for CNS Pharmaceuticals as of November 20, 2024 is 0.12.
An investor who bought $1,000 worth of CNS Pharmaceuticals stock at the IPO in 2019 would have $-1,000 today, roughly -1 times their original investment - a -88.75% compound annual growth rate over 5 years.
The all-time high CNS Pharmaceuticals stock closing price was 7485.00 on January 10, 2020.
The CNS Pharmaceuticals 52-week high stock price is 121.00, which is 100733.3% above the current share price.
The CNS Pharmaceuticals 52-week low stock price is 0.10, which is 16.7% below the current share price.
The average CNS Pharmaceuticals stock price for the last 52 weeks is 17.02.
An investor who bought $1,000 worth of CNS Pharmaceuticals stock at the IPO in 2019 would have $-1,000 today, roughly -1 times their original investment - a -88.75% compound annual growth rate over 5 years.
The all-time high CNS Pharmaceuticals stock closing price was 7485.00 on January 10, 2020.
The CNS Pharmaceuticals 52-week high stock price is 121.00, which is 100733.3% above the current share price.
The CNS Pharmaceuticals 52-week low stock price is 0.10, which is 16.7% below the current share price.
The average CNS Pharmaceuticals stock price for the last 52 weeks is 17.02.